Judy Gets Her Freakonomics On

Key Takeaways

• Epic boasts the most APIs among EHR vendors.
• Faulkner says data access requires healthcare organization permission.
• API quantity doesn't guarantee developer-friendly experience.
• Platform design can still block third‑party app functionality.
• Ongoing antitrust scrutiny heightens risk for Epic's interoperability stance.

Pulse Analysis

The recent Freakonomics interview with Epic Systems founder and CEO Judy Faulkner put a spotlight on the company’s claim of having the largest number of application programming interfaces (APIs) in the electronic health record (EHR) market. While the metric sounds impressive, it masks a more complex reality. Competitors such as Cerner and Allscripts have been expanding their API ecosystems, yet Epic’s sheer count remains a headline statistic that the firm leverages to portray openness. The conversation, however, stopped short of evaluating the quality or accessibility of those interfaces.

Faulkner emphasized that Epic does not ‘own’ patient data and therefore requires permission from each health system before any third‑party app can retrieve information. In practice, this permission model creates a bottleneck: developers must negotiate with individual hospitals, navigate varying consent policies, and contend with undocumented edge cases. Moreover, the presence of an API does not guarantee a smooth developer experience; documentation depth, sandbox environments, pricing structures, and predictable usage limits are equally critical. When platform design restricts what can be done with the data, the API count alone becomes a hollow promise.

The interview briefly touched on information‑blocking concerns, a hot topic as the U.S. Department of Health and Human Services tightens antitrust enforcement on EHR vendors. Regulators are scrutinizing whether Epic’s permission requirements and opaque integration pathways constitute unlawful barriers to competition. For health systems, this could mean pressure to adopt more interoperable solutions or face penalties. For developers, the stakes are higher: limited access hampers innovation in patient‑centered apps and may shift investment toward more open platforms. Epic’s strategic response will shape the next wave of digital health competition.